Gain-of-function mutations of SCN9A are the cause of two hereditary pain disorders, inherited erythromelalgia (IEM) and paroxysmal extreme pain disorder (PEPD)5, 6, 7. Here, SCN9A is linked to paroxysmal extreme pain disorder.